Asymchem

IPO

Innovative CDMO Solutions in an Ever-Changing World

Public · Tianjin, China · Founded 1999 · $2.3B raised

Headquarters
Tianjin
Employees
5001–10000
Founded
1999
Business Model
B2B
Total Funding
$2.3B
Last Round
$2.3B Private EquityFeb 2020
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Asymchem is a global contract development and manufacturing organization (CDMO) founded in 1999, providing integrated R&D and one-stop production services to the world's top pharmaceutical companies. The company offers comprehensive CMC services covering the full lifecycle of drug development — from early clinical stage through commercial manufacturing — including advanced intermediates, APIs, formulations, and clinical research services. Asymchem is a recognized leader in green chemistry and novel manufacturing technologies including continuous flow chemistry, biocatalysis, fermentation, and electrochemistry, enabling cost-effective and environmentally responsible pharmaceutical synthesis.

Summary

Asymchem is a Biotech company based in Tianjin, China, founded in 1999. It has raised $2.3B in total across 2 rounds, most recently a $2.3B Private Equity round in Feb 2020. Investors include Goldman Sachs and Tianyi Medical Private Equity.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPODec 2021

Sign up to see all 3 events

Funding: Venture Round through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Asymchem on Indexed.vc
<a href="https://indexed.vc/companies/asymchem"><img src="https://indexed.vc/api/badge/company/asymchem" alt="Asymchem on Indexed.vc" width="260" height="76" /></a>